Benlysta 49401-0088-47
Generic: Belimumab
- Manufacturer
- Glaxosmithkline Llc
- Dosage Form
- Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 20, 2017
- Listing Expires
- December 31, 2027
- Application
- BLA761043
Need to source Benlysta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Belimumab | 200 mg/mL |
Drug Class
B Lymphocyte Stimulator-specific Inhibitor [EPC]B Lymphocyte Stimulator-directed Antibody Interactions [MoA]B Lymphocyte Stimulator-specific Inhibitor [EPC]
Selected Package
49401-0088-47Selected4 SYRINGE in 1 CARTON (49401-088-47) / 1 mL in 1 SYRINGE (49401-088-42)
Other packages for this product(4)
1 SYRINGE in 1 CARTON (49401-088-02) / 1 mL in 1 SYRINGE (49401-088-01)
4 SYRINGE in 1 CARTON (49401-088-35) / 1 mL in 1 SYRINGE (49401-088-01)
1 SYRINGE in 1 CARTON (49401-088-50) / 1 mL in 1 SYRINGE (49401-088-42)
1 SYRINGE in 1 CARTON (49401-088-61) / 1 mL in 1 SYRINGE